Pharmacy activity in the earliest stages of a workers’ compensation claim can serve as a measurable signal of elevated risk for future complexity, cost, and duration.
As part of our continuing Social Determinants of Health (SDoH) series, we examine how low health literacy can delay recovery, increase costs, and worsen claim outcomes.
Drug shortages are no longer just a pharmacy issue but a growing claims management risk in workers’ compensation, contributing to more complex claims, delayed care, and higher costs.
The medications used to treat lung diseases are diverse. While patient-specific factors can help determine course of treatment, there are larger considerations for the pharmacy management of lung conditions.
These diseases are infrequent, but they can incur significant costs as they can be present for life, requiring ongoing monitoring, treatment, and medication.
Dermatological agents remained a significant cost driver, in part due to physician dispensing and delivery pharmacies, which accounted for a significant number of high-cost transactions.
